Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

[Botulinum toxin type A (Relatox) in transition from medication overuse to non-overuse status in patients with chronic migraine: a subgroup analysis of phase IIIb randomized single-blind multicenter active-controlled parallel-group trial].

Autor: Artemenko AR; Sechenov First Moscow State Medical University of (Sechenov University), Moscow, Russia.; LLC «Medical Center «Practical Neurology», Moscow, Russia., Abramov VG; Federal Siberian Scientific and Clinical Center, Krasnoyarsk, Russia., Bozhenkina TV; Federal Siberian Scientific and Clinical Center, Krasnoyarsk, Russia., Konovalova ZN; LLC «Central Institute of Botulinotherapy and Actual Neurology», Moscow, Russia., Korenko AN; LLC «Professorial Clinic «Oda», St. Petersburg, Russia.; Academian I.P. Pavlov First Saint Petersburg State Medical University, St. Petersburg, Russia., Krasavina DA; LLC «Professorial Clinic «Oda», St. Petersburg, Russia.; Staint Petersburg State Pediatric Medical University, St. Petersburg, Russia., Kurenkov AL; LLC «Medical Center «Practical Neurology», Moscow, Russia.; National Medical Research Center for Children's Health, Moscow, Russia., Latysheva NV; Sechenov First Moscow State Medical University of (Sechenov University), Moscow, Russia.; LLC «Cephalgologist», Moscow, Russia., Naprienko MV; Sechenov First Moscow State Medical University of (Sechenov University), Moscow, Russia.; LLC «Cephalgologist», Moscow, Russia., Orlova OR; Sechenov First Moscow State Medical University of (Sechenov University), Moscow, Russia.; LLC «Central Institute of Botulinotherapy and Actual Neurology», Moscow, Russia., Filatova EG; Sechenov First Moscow State Medical University of (Sechenov University), Moscow, Russia.; LLC «Cephalgologist», Moscow, Russia., Shevchenko VS; LLC «Medical Center «Practical Neurology», Moscow, Russia.; Treatment and Rehabilitation Center, Moscow, Russia., Iakovleva PN; LLC «Central Institute of Botulinotherapy and Actual Neurology», Moscow, Russia.

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2023; Vol. 123 (11), pp. 64-74.

[Changes of the spasticity patterns in children with cerebral palsy GMFCS III at the age of 2 to 12 years].

Autor: Kurenkov AL; National Medical Research Center for Children's Health, Moscow, Russia., Kuzenkova LM; National Medical Research Center for Children's Health, Moscow, Russia., Fisenko DA; Lomonosov Moscow State University, Moscow, Russia., Klochkova OA; National Medical Research Center for Children's Health, Moscow, Russia., Bursagova BI; National Medical Research Center for Children's Health, Moscow, Russia., Chernikov VV; National Medical Research Center for Children's Health, Moscow, Russia.

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2020; Vol. 120 (6), pp. 36-44.

[Botulinum toxin type A (Incobotulinum toxin A) in spastic forms of cerebral palsy: a retrospective analysis of clinical experience].

Autor: Kurenkov AL; National Medical Research Center for Children's Health, Moscow, Russia., Kuzenkova LM; National Medical Research Center for Children's Health, Moscow, Russia., Bursagova BI; National Medical Research Center for Children's Health, Moscow, Russia., Klochkova OA; National Medical Research Center for Children's Health, Moscow, Russia., Chernikov VV; National Medical Research Center for Children's Health, Moscow, Russia., Kuznetsova MA; National Medical Research Center for Children's Health, Moscow, Russia., Ashrafova US; National Medical Research Center for Children's Health, Moscow, Russia., Kuprianova OS; National Medical Research Center for Children's Health, Moscow, Russia.

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2020; Vol. 120 (7), pp. 68-77.

[Efficacy and safety of botulinum toxin type A (IncobotulinumtoxinA) in the treatment of patients with cerebral palsy].

Autor: Kurenkov AL; National medical research center of Children Health, Ministry of Health of Russia, Moscow, Russia., Klochkova OA; National medical research center of Children Health, Ministry of Health of Russia, Moscow, Russia., Bursagova BI; National medical research center of Children Health, Ministry of Health of Russia, Moscow, Russia., Karimova HM; National medical research center of Children Health, Ministry of Health of Russia, Moscow, Russia., Kuzenkova LM; National medical research center of Children Health, Ministry of Health of Russia, Moscow, Russia., Mamedyarov AM; National medical research center of Children Health, Ministry of Health of Russia, Moscow, Russia., Namazova-Baranova LS; National medical research center of Children Health, Ministry of Health of Russia, Moscow, Russia., Agranovich OV; Stavropol State Medical University, Ministry of Healthcare of Russia, Stavropol, Russia., Agranovich AO; Regional Pediatric Clinic, Stavropol Kray, Stavropol, Russia., Soboleva OA; Regional Pediatric Clinic, Stavropol Kray, Stavropol, Russia., Khapaeva MM; Regional Pediatric Clinic, Stavropol Kray, Stavropol, Russia., Batysheva TT; Research-to-Practice Center of Pediatric Psychiatry and Neurology, Healthcare Department of Moscow City, Moscow, Russia., Sarzhina MN; Research-to-Practice Center of Pediatric Psychiatry and Neurology, Healthcare Department of Moscow City, Moscow, Russia.

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2017; Vol. 117 (11), pp. 37-44.